Updated Oct 9, 2026 · 05:00 UTC
REGNRegeneron Pharmaceuticals, Inc.
Health Care · United States · XNAS · pharmaceutical preparations
$739.15−0.34%last session · market closed
Market cap
$76.10b
real-world
Tokenized
$11k
<0.001% of the asset
Avg token price
$741.49
+0.32% vs real
Spot volume, 24h
—
Derivatives, 24h
—
Perp open interest
—
In DeFi
—
REGN · Price
Apr 28, 2025low $485.54 · high $858.19 · now $742.12Oct 8, 2026
Earnings
Nasdaq’s earnings calendar
Next earnings
Oct 30
before the open · Sep 2026 quarter · EPS forecast $13.51 (6 analysts)
Last earnings, Jul 30
$12.53 EPS
+56.6% vs $8.00 forecast · Jun 2026 quarter
Real market
Regeneron Pharmaceuticals Inc
Last close
$742.12
Oct 7
Traded on Oct 7
$466.1m
Price now
$739.15
market closed
Where it trades
24h volume by venue, as the exchanges report it · open interest and funding on the perpetuals
Spot · — · 0 venues
None yet
Derivatives · — · 0 venues
None yet
Onchain versions
2 tokens from 2 issuers
REGNonOndo Assetstied here$741.49$11k
wREGNxBacked Assets——By chain
Where the tokens circulate, issuers’ unsold stock taken off
In DeFi
Pools and lending markets that hold these tokens
None found
Business 12 months to Jun 2026 · SEC EDGAR
Results
Revenue
$15.53b
+9% YoY
Operating income
$3.84b
25% margin · +0% YoY
Net income
$4.33b
28% margin · −3% YoY
EPS, diluted
$40.84
−1% YoY
Cash and balance sheet
Free cash flow
$3.76b
24% of revenue
Net cash
$15.84b
$17.82b cash and securities, $1.99b debt
Diluted shares
106m
−2% YoY
Valuation at today’s market cap
P/E
18×
EV / sales
3.9×
enterprise value $60.26b
EV / operating income
15.7×
Free cash flow yield
4.9%
Quarterly
RevenueNet income